Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma

Por Kurokawa, C, Geekiyanage, H, Allen, C, Iankov, I, Schroeder, M, Carlson, B, Bakken, K, Sarkaria, J, Ecsedy, JA, D’Assoro, A, Friday, B, Galanis, E
Publicado no J Neurooncol (2016)

Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention

Por McCubrey, J A, Steelman, L S, Bertrand, F E, Davis, N M, Abrams, S L, Montalto, G, D'Assoro, A B, Libra, M, Nicoletti, F, Maestro, R, Basecke, J, Cocco, L, Cervello, M, Martelli, A M
Publicado em 2014